Experimental design and modelling approach to evaluate efficacy of β-lactam/β-lactamase inhibitor combinations

As a framework for translational predictions, the goal of this modelling strategy is to significantly decrease the decision-making time by running clinical trial simulations with MIC-substituted EC50 function for isolates of comparable susceptibility through established correlation between BL MIC and EC50 values.